Participants in PATH had significantly greater reduction in depression ( Cohen d , 0.60 ; 95 % CI , 0.13-1 .06 ; treatment time , F ( 1,179 ) = 8.03 ; P = .005 ) and disability ( Cohen d , 0.67 ; 95 % CI , 0.20-1 .14 ; treatment time , F ( 1,169 ) = 14.86 ; P = .001 ) than ST-CI participants during the 12-week period ( primary outcomes ) .